| HMDB0003375 | (+)-Limonene | 5989-27-5 |  | C10H16 | 136.234 136.125200512 | Not Available |
| HMDB0059608 | (+)-trans-Carveol | 18383-51-2 |  | C10H16O | 152.2334 152.120115134 | Not Available |
| HMDB0004321 | (-)-Limonene | 5989-54-8 |  | C10H16 | 136.234 136.125200512 | Not Available |
| HMDB0003450 | (-)-trans-Carveol | 2102-58-1 |  | C10H16O | 152.2334 152.120115134 | Not Available |
| HMDB0004684 | 11,12,15-THETA | |  | C20H34O5 | 354.481 354.240624198 | Not Available |
| HMDB0004673 | 11,12-Epoxyeicosatrienoic acid | 123931-40-8 |  | C20H32O3 | 320.473 320.23514489 | Not Available |
| HMDB0004694 | 11,14,15-THETA | |  | C20H34O5 | 354.481 354.240624198 | Not Available |
| HMDB0004693 | 11H-14,15-EETA | 219535-29-2 |  | C20H32O4 | 336.4657 336.230059512 | Not Available |
| HMDB0004702 | 12,13-EpOME | |  | C18H32O3 | 296.4449 296.23514489 | Not Available |
| HMDB0004264 | 14,15-Epoxy-5,8,11-eicosatrienoic acid | 81276-03-1 |  | C20H32O3 | 320.4663 320.23514489 | Not Available |
| HMDB0004244 | 15(S)-HPETE | 70981-96-3 |  | C20H32O4 | 336.4657 336.230059512 | Not Available |
| HMDB0005050 | 15H-11,12-EETA | 877878-78-9 |  | C20H32O4 | 336.4657 336.230059512 | Not Available |
| HMDB0004680 | 16(R)-HETE | |  | C20H32O3 | 320.4663 320.23514489 | Not Available |
| HMDB0011136 | 19(S)-HETE | 79551-85-2 |  | C20H32O3 | 320.4663 320.23514489 | Not Available |
| HMDB0003955 | 19-Hydroxyandrost-4-ene-3,17-dione | 510-64-5 |  | C19H26O3 | 302.4079 302.188194698 | Not Available |
| HMDB0006769 | 19-Hydroxytestosterone | 2126-37-6 |  | C19H28O3 | 304.4238 304.203844762 | Not Available |
| HMDB0006768 | 19-Oxoandrost-4-ene-3,17-dione | |  | C19H24O3 | 300.3921 300.172544634 | Not Available |
| HMDB0003959 | 19-Oxotestosterone | 4075-13-2 |  | C19H26O3 | 302.4079 302.188194698 | Not Available |
| HMDB0014024 | 2-Hydroxychlorpropamide | 36892-36-1 |  | C10H13ClN2O4S | 292.739 292.028455311 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
|
| HMDB0013929 | 2-Oxoclopidogrel | |  | C16H16ClNO3S | 337.821 337.05394178 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
|
| HMDB0013895 | 3',4'-Dihydrodiol | |  | C15H14N2O4 | 286.2827 286.095356946 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
- Levy RH: Cytochrome P450 isozymes and antiepileptic drug interactions. Epilepsia. 1995;36 Suppl 5:S8-13. [PubMed:8806399 ]
- Komatsu T, Yamazaki H, Asahi S, Gillam EM, Guengerich FP, Nakajima M, Yokoi T: Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4. Drug Metab Dispos. 2000 Nov;28(11):1361-8. [PubMed:11038165 ]
- Kaminsky LS, Zhang ZY: Human P450 metabolism of warfarin. Pharmacol Ther. 1997;73(1):67-74. [PubMed:9014207 ]
|
| HMDB0013940 | 3'-Hydroxyhexobarbital | 427-29-2 |  | C12H16N2O4 | 252.2664 252.11100701 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
- Lewis DF, Modi S, Dickins M: Structure-activity relationship for human cytochrome P450 substrates and inhibitors. Drug Metab Rev. 2002 Feb-May;34(1-2):69-82. [PubMed:11996013 ]
- Adedoyin A, Prakash C, O'Shea D, Blair IA, Wilkinson GR: Stereoselective disposition of hexobarbital and its metabolites: relationship to the S-mephenytoin polymorphism in Caucasian and Chinese subjects. Pharmacogenetics. 1994 Feb;4(1):27-38. [PubMed:8004130 ]
|
| HMDB0013858 | 3-Dechloroethylifosfamide | 36761-83-8 |  | C5H12ClN2O2P | 198.588 198.032491857 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Roy P, Yu LJ, Crespi CL, Waxman DJ: Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles. Drug Metab Dispos. 1999 Jun;27(6):655-66. [PubMed:10348794 ]
|
| HMDB0013840 | 3-Hydroxymethylantipyrine | 18125-49-0 |  | C11H12N2O2 | 204.2252 204.089877638 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
|
| HMDB0013974 | 4'-Hydroxydiclofenac | 64118-84-9 |  | C14H11Cl2NO3 | 312.148 311.011598637 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
|